France
OPM is a technological company specialized in precision medicine. OPM's mission is to bring innovative therapeutic and diagnostic solutions to treat therapeutic resistance and metastasis evolution. The patient is at the centre of our reflexion, of our unique innovative model, and our investments.
For OPM "our collective success is paramount", there can be no value creation without exchange, without dialogue. The value creation resulting for us from reciprocity, i.e. balanced and fair exchanges at all levels, whether between internal collaborators, or with our partners, therapists, patients, experts and investors.
Founded in 2022, OPM operates in the Biotechnology, Health Care, Health and Wellness industries and is headquartered in France. Their last investment, a €6.00M Post-IPO Debt investment, took place on 04 October 2023 and was secured from Société Générale, Crédit Agricole Private Bank, Caisse d’Epargne.
To discuss partnership or investment, don't hesitate to get in touch: [email protected]
